Telehealth Fees was Vsee Health’s largest product and service line in fiscal 2025, bringing in $11.59M of $43.85M (26%).
| Product and Service | FY 2023 | FY 2023 | FY 2024 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Subscription Fees | — | $12.13M | — | $12.35M | $9.69M |
| Telehealth Fees | — | — | — | $3.01M | $11.59M |
| Patient Fees | — | — | — | $3.62M | $10.13M |
| Professional Services & Other Fees | — | $3.19M | — | $6.32M | $9.31M |
| Technical Engineering Fees | $2.50M | $1.97M | $7.33M | $5.94M | $3.13M |
| Institutional Fees | — | — | — | $20.64K | $7.50K |
| Total | $2.50M | $17.30M | $7.33M | $31.26M | $43.85M |
Vsee Health brought in $43.85M from its six product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 40.3% from $31.26M in fiscal 2024. Telehealth Fees was the largest at $11.59M (26.4%), ahead of Patient Fees at $10.13M (23.1%) and Subscription Fees at $9.69M (22.1%). The other three lines brought in $12.44M combined.
Compared with fiscal 2024, Telehealth Fees grew fastest, up 284.9% to $11.59M, while Technical Engineering Fees fell the most, down 47.3% to $3.13M.
Vsee Health began breaking out Telehealth Fees in fiscal 2024, Patient Fees in fiscal 2024 and Institutional Fees in fiscal 2024.
Transferred At Point In Time was Vsee Health’s largest revenue line in fiscal 2025, bringing in $31.04M of $43.85M (71%).
| Timing of Transfer of Good or Service | FY 2024 | FY 2025 |
|---|---|---|
| Transferred At Point In Time | $15.88M | $31.04M |
| Transferred Over Time | $15.39M | $12.82M |
| Total | $31.26M | $43.85M |
Vsee Health brought in $43.85M from its two revenue lines in fiscal 2025, the year ended December 31, 2025. That was up 40.3% from $31.26M in fiscal 2024. Transferred At Point In Time was the largest at $31.04M (70.8%), ahead of Transferred Over Time at $12.82M (29.2%).
Compared with fiscal 2024, Transferred At Point In Time grew 95.5% to $31.04M, while Transferred Over Time fell 16.7% to $12.82M.
Telehealth was Vsee Health’s largest segment in fiscal 2025, bringing in $11.59M of $21.28M (54%).
| Segment | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Technology | $12.13M | $12.35M | $9.69M |
| Telehealth | — | $3.62M | $11.59M |
| Total | $12.13M | $15.97M | $21.28M |
Vsee Health brought in $21.28M from its two segments in fiscal 2025, the year ended December 31, 2025. That is less than the $43.85M it reports by product and service, so these segments do not cover all of its revenue. Telehealth was the largest at $11.59M (54.5%), ahead of Technology at $9.69M (45.5%).
Compared with fiscal 2024, Telehealth grew 219.9% to $11.59M, while Technology fell 21.5% to $9.69M.
Vsee Health began breaking out Telehealth in fiscal 2024, when it brought in $3.62M.
Vsee Health (VSEE) reports its revenue by product and service, by timing of transfer of good or service and by segment. In fiscal 2025, Telehealth Fees was its largest product and service line, bringing in $11.59M (26.4% of the total), followed by Patient Fees at $10.13M (23.1%).
Telehealth Fees was Vsee Health's largest product and service line in fiscal 2025, bringing in $11.59M, or 26.4% of the $43.85M total across its six product and service lines.
Transferred At Point In Time was Vsee Health's largest revenue line in fiscal 2025, bringing in $31.04M, or 70.8% of the $43.85M total across its two revenue lines.
Telehealth was Vsee Health's largest segment in fiscal 2025, bringing in $11.59M, or 54.5% of the $21.28M total across its two segments.
Among Vsee Health's product and service lines that make up at least 2% of revenue, Telehealth Fees grew fastest in fiscal 2025, up 284.9% from $3.01M to $11.59M.
Every figure comes from Vsee Health's annual financial filings, as reported. Each line keeps the name Vsee Health gives it, and years follow its fiscal calendar.
Vsee Health's revenue by product and service goes back to fiscal 2023, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.